General Counsel
Gilead Sciences, Inc. (GILD)Equibles does not estimate personal net worth.
Keely Kane-Wetton is recorded as General Counsel at Gilead Sciences, Inc. (GILD). Keely Kane-Wetton has spoken on 1 investor event across 1 company, most recently for Gilead Sciences, Inc. on April 30, 2026. Gilead Sciences, Inc. is classified in the Drug Manufacturers - General industry within the Healthcare sector. Other leadership on record at Gilead Sciences, Inc. includes Daniel P. O’Day (CEO), Robin L. Washington (CFO), Diane E. Wilfong (Chief Accounting Officer) and 7 others.
“I have a complete list of the stockholders of record of the company's common stock on March 6, 2026, the record date for this meeting. I also have an affidavit from Broadridge certifying that a notice of annual meeting of stockholders of the company was disseminated to all stockholders of record on the record date.”
Drug Manufacturers - General · Healthcare
General Counsel
